Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Large-scale proteomics reveals precise biomarkers for detection of ovarian cancer in symptomatic women

27 Jul 2024

Abstract excerpt

Ovarian cancer is the 8th most common cancer among women and has a 5-year survival of only 30-50%. While the survival is close to 90% for stage I tumours it is only 20% for stage IV. Current biomarkers are not sensitive nor specific enough, and novel biomarkers are urgently needed. We used the Explore PEA technology for large-scale analysis of 2943 plasma proteins to search for new biomarkers using two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Cancer, Lipids, and Metabolism
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39068297
DOI: 10.1038/s41598-024-68249-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Large-scale proteomics reveals precise biomarkers for detection of ovarian cancer in symptomatic womenPMID 39068297Read ↗

Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancerSemantic proximity Read ↗

A novel proteomics-based plasma test for early detection of multiple cancers in the general populationSemantic proximity Read ↗

High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancerSemantic proximity Read ↗

Identifying proteomic risk factors for cancer using prospective and exome analyses: 1,463 circulating proteins and risk of 19 cancers in the UK BiobankSemantic proximity Read ↗

Plasma protein and tumor tissue gene expression analyses in ovarian cancer reveals differentially co-regulated clusters between benign and malignant conditionsSemantic proximity Read ↗

Applications of Proteomics in Ovarian Cancer: Dawn of a New EraSemantic proximity Read ↗

Prospective Proteomic Study Identifies Potential Circulating Protein Biomarkers for Colorectal Cancer RiskSemantic proximity Read ↗

Multi-analyte approach combining cfDNA sequencing and protein testing for early ovarian cancer detectionSemantic proximity Read ↗

Phenome-wide association study of ovarian cancer identifies common comorbidities and reveals shared genetics with complex diseases and biomarkersSemantic proximity Read ↗

Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein BiomarkersSemantic proximity Read ↗

Preneoplastic lesions fimbria pan-proteomic studies establish the fimbriectomy benefit for BRCA1/2 patients and identify early diagnosis markers of HGSCSemantic proximity Read ↗

Identification of Candidate Plasma Protein Biomarkers for Cervical Cancer Using the Multiplex Proximity Extension AssaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.